Q4 2024 Earnings Call Transcript March 10, 2025 Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is ...

Equities research analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a ...

Detailed price information for Fennec Pharmaceuticals Inc (FRX-T) from The Globe and Mail including charting and trades.

Analysts at HC Wainwright upped their Q1 2025 EPS estimates for Fennec Pharmaceuticals in a report issued on Tuesday, March ...

Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call. (Operator Instructions) As a reminder, today's ...

Algeria national team coach Vladimir Petkovic announced on Friday a 26-man squad for Fennec Foxes’ upcoming World Cup ...

Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings and Corporate Update Conference Call. At this time, all participants are in a ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year.

Reports Q4 revenue $7.93M, consensus $16.42M. “2024 marked the beginning of a foundational transformation for Fennec (FENC), setting the stage ...